Serina Therapeutics, Inc. (SER)
1.35
-0.30
(-18.18%)
USD |
NYAM |
Nov 06, 10:25
Serina Therapeutics Net Income (Quarterly) : -6.356M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.356M |
| March 31, 2026 | -6.898M |
| December 31, 2025 | -3.336M |
| September 30, 2025 | -4.595M |
| June 30, 2025 | -6.462M |
| March 31, 2025 | -4.822M |
| September 30, 2024 | 1.383M |
| June 30, 2024 | 5.177M |
| March 31, 2024 | -15.02M |
| December 31, 2023 | 1.051M |
| September 30, 2023 | 1.752M |
| June 30, 2023 | 0.808M |
| March 31, 2023 | 1.658M |
| December 31, 2022 | -2.761M |
| September 30, 2022 | -2.436M |
| June 30, 2022 | -2.618M |
| March 31, 2022 | -2.707M |
| December 31, 2021 | -2.159M |
| September 30, 2021 | -1.955M |
| Date | Value |
|---|---|
| June 30, 2021 | -2.475M |
| March 31, 2021 | -1.993M |
| December 31, 2020 | -2.41M |
| September 30, 2020 | -2.524M |
| June 30, 2020 | -2.432M |
| March 31, 2020 | -3.033M |
| December 31, 2019 | -2.741M |
| September 30, 2019 | -3.277M |
| June 30, 2019 | -3.155M |
| March 31, 2019 | -3.211M |
| December 31, 2018 | -3.274M |
| September 30, 2018 | -2.185M |
| June 30, 2018 | -1.951M |
| March 31, 2018 | -0.321M |
| December 31, 2017 | -1.544M |
| September 30, 2017 | -2.011M |
| June 30, 2017 | -0.322M |
| March 31, 2017 | -2.76M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 6.356M |
| EPS Diluted (Quarterly) | -0.5451 |
| Enterprise Value | 22.10M |
| Earnings Yield | -139.1% |
| Normalized Earnings Yield | -165.80 |